next-generation cardiac remote monitoring solution launched in 2015, leverages mobile and cloud
technology to facilitate detection of cardiovascular arrhythmias. ZywiePro enables physicians to
provide more personalized and effective patient care by detailed diagnostic insight into the
cardiovascular health of the patients. However, factors inhibiting the cardiac monitoring devices
market include high cost of device and lack of knowledge about advance cardiac monitoring
devices.
Advance cardiac monitoring devices enable physician to make accurate diagnosis and determine a
treatment plan. For instance, the Reveal LINQ Insertable Cardiac Monitor manufactured by
Medtronic, approved by FDA in 2014, is currently the smallest heart monitor in the market. It can
diagnose the cause of infrequent, unexplained fainting spells better than conventional testing.
North America is expected to dominate the cardiac monitoring devices market over the
forecast period, owing to increasing prevalence of cardiovascular diseases in the region
Regional segmentation of cardiac monitoring devices market by Coherent Market Insights
comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America is expected to hold a dominant position in global cardiac monitoring devices market over
the forecast period, due to increasing prevalence of cardiovascular diseases in the region. According
to the American Heart Association (AHA), 2017, about 92.1 million adults in the U.S. are suffering
from some form of cardiovascular disease or the after-effects of stroke. AHA also stated in its
report, that direct and indirect costs of cardiovascular diseases and stroke are estimated to account
for US$ 316 billion, including health expenditures and lost productivity. Growth in Europe market
is driven by emergence of innovative cardiac solutions offered by regional manufacturers and rising
cases of cardiovascular diseases. For instance, LifeWatch —manufacturer of two innovative Mobile
Cardiac Telemetry (MCT) solutions — LifeWatch MCT 3 Lead and LifeWatch MCT 1 Lead Patch
detects, records, and wirelessly transmits asymptomatic and symptomatic arrhythmia to clinicians
for analysis. According to European Heart Network and European Society of Cardiology 2015, over
85 million people suffer from cardiovascular disease (CVD) every year, causing over 4 million
deaths in Europe.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/cardiac-
monitoring-devices-market-1272
Asia Pacific is also expected to witness high growth. This is attributed to availability of
technological advanced products and rising healthcare concern for stroke prevention associated with
atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population
with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of whom 2.9 million may
suffer from AF-associated strokes.
Increasing FDA clearance for new and innovative products is a major factor fueling cardiac
monitoring devices market growth
In 2016, the FDA approved wireless continuous non-invasive 'Beat-by-Beat' blood pressure and
heart rate monitor manufactured by CareTaker Medical based on patented finger cuff technology.
The device allows physicians to remotely monitor medical-grade continuous blood pressure and
heart rate from anywhere, using only a patient friendly-finger cuff. Key players in cardiac
monitoring devices market are Philips Healthcare, Medtronic, Boston Scientific, Cardiac Science,
LifeWatch, CareTaker Medical, Spacelabs, St. Jude Medical, Kohden, CardioNet, and Mortara
Instrument.
Market Taxonomy: